Meningococcal vaccine. 2016 Clinical Pharmacology. Accessed 10/26/16 from http://clinicalpharmacology.com
Advisory Committee on Immunization Practices (ACIP) and Centers for Disease Control and Prevention (CDC). Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2013. Accessed 10/26/16 from http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6202a1.htm
Advisory Committee on Immunization Practices (ACIP) and Centers for Disease Control and Prevention (CDC). Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk for Meningococcal Disease: Recommendations of ACIP, 2013. Accessed 10/24/16 from http://www.cdc.gov/mmwr/pdf/wk/mm6324.pdf
Menveo [meningococcal (groups a, c, y and w-135) oligosaccharide diphtheria crm197 conjugate vaccine]. 2016 Novartis. Accessed 10/26/16 from https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89dde472-1efb-4630-88bc-41cde216fb3a
Menactra (Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine. 2016 Sanofi. Accessed 10/26/16 from https://www.vaccineshoppe.com/image.cfm?doc_id=12580&image_type=product_pdf.